Serum and Tumor PD-L1 Expression and Aggressive Clinicopathologic Features in Papillary Thyroid Carcinoma

Дата публикации: 13-08-2026 00:00:00

This cohort study evaluates whether serum programmed cell death 1 ligand 1 (PD-L1) levels and tumor PD-L1 expression are associated with aggressive clinicopathologic features of papillary thyroid carcinoma.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Pathological response and exploratory assessment of pretreatment PD-L1 combined positive score after four cycles of neoadjuvant pembrolizumab plus chemotherapy in locally advanced head and neck squamous cell carcinoma: a retrospective cohort study	0	13.96	07-08-2026
2	PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression	0	15.58	01-07-2026
3	Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors	0	7	25-06-2026
4	Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis	0	4.7	01-07-2026
5	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer	0	5	18-06-2026
6	Late Extensive Regional Recurrence of Paratesticular Dedifferentiated Liposarcoma 10 Years after Orchiectomy: A Case Report	0	7.34	01-04-2026
7	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
8	Superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) for maxillary sinus squamous cell carcinoma: an institutional experience of 118 cases	0	20.34	10-08-2026
9	Treatment Dependent Response Modeling Using Morphologic and Qualitative Features from Perfusion and Contrast-Enhanced Susceptibility Imaging in Undifferentiated Pleomorphic Sarcoma: A Comparison of Radiation Alone Versus Consecutive Chemotherapy and Radiation	0	13.58	07-08-2026
10	Errors in Figures	0	12.94	01-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.37. Источник: jamanetwork.com.